Cologuard® revenue increased 158 percent to $73 million during third quarter
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Exact Sciences (EXAS) PT Raised to $61 at Craig-Hallum
October 31, 2017 7:24 AM EDTCraig-Hallum analyst Kevin Ellich raised his price target on Exact Sciences (NASDAQ: EXAS) to $61.00 while maintaining a Buy rating following strong beat and raise results.
... MoreExact Sciences (EXAS) Tops Q3 EPS by 7c; Guides Above Views
October 30, 2017 4:09 PM EDTExact Sciences (NASDAQ: EXAS) reported Q3 EPS of ($0.23), $0.07 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $72.6 million versus the consensus estimate of $65.02 million.
GUIDANCE:
Exact Sciences sees FY2017 revenue of $254-257 million, versus the consensus of... More
